Track topics on Twitter Track topics that are important to you
457 North Harrison Street
United States of America
Phone: 1 609 430-2481
Fax: 1 609 430-2482
Genmab A/S has published its Articles of Association dated November 14, 2017. The Articles of Association can be found on Genmab's website: http://ir.genmab.com/releases.cfm Contact: Rachel Curtis ...
Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a great example for other European biotechs to follow. Genmab has officially joined the elite of the biotech world ...
Media Release -- Over 25 abstracts on Genmab partnered programs scheduled for presentation at ASH -- Daratumumab: 6 oral presentations; Total of over 20 abstracts accepted including ISSCopenhagen, ...
By Ben Hirschler LONDON (Reuters) - Genmab was Europe's second biggest biotech company, until its partner Johnson & Johnson bought Switzerland's Actelion for $30 billion this year and propelled the...
Media Release -- R&D Update to be held live in Atlanta, Georgia -- Key Opinion Leaders to discuss daratumumab and tisotumab vedotin data -- Discussion of Genmab's pipeline, 2017 progress & company ...
Company AnnouncementCopenhagen, Denmark; February 21, 2018 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2017. Below is a summary of business progress and financial pe...
Media ReleaseCopenhagen, Denmark; November 7, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the company's CEO, Jan van de Winkel, Ph.D., will present an update at the Jefferies 20...
Media ReleaseCopenhagen, Denmark; January 2, 2018 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 36th Annual J.P....
Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat c...
Genmab is a leading international biotechnology company that aims to improve the lives of patients by creating and developing innovative antibody products. The company was founded in Copenhagen, Den...
TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights ...
We have published hundreds of Genmab Inc. news stories on BioPortfolio along with dozens of Genmab Inc. Clinical Trials and PubMed Articles about Genmab Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genmab Inc. Companies in our database. You can also find out about relevant Genmab Inc. Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers) - Mouth cancer can develop on the lip, the tongue, the floor...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...